Postnatal dependence of plasma copper and zinc levels on gestational age and maturity observed in infants fed a high zinc content formula.
We studied the effect of gestational age and maturity on plasma zinc and copper levels at 10 and 120 days of age. The association of plasma zinc changes and body growth was also investigated. Infants were receiving a controlled intake of zinc and copper solely through a zinc-supplemented formula (4.7 mg/L of zinc and 0.16 mg/L of copper). Twenty-eight low-birthweight infants (less than 2,500 g) having gestational ages ranging from 33 to 40 weeks [17 with an appropriate birthweight for gestational age (AGA) and 11 small for gestational age (SGA)] were enrolled in the present study. Measurements of plasma zinc and copper concentration, weight, length, head circumference, and tricipital and subscapular skinfolds were carried out at 10 and 120 days of age. Proton-induced x-ray fluorescence technique (PIXE) was used to assess copper and zinc concentrations. At 10 days of age a significant correlation between copper concentration and gestational age was found. At 120 days of age the copper concentration was higher than at 10 days and independent of gestational age and maturity (mean +/- SEM = 116 +/- 5 micrograms/dl). At 10 days of age no significant correlation between zinc content and gestational age was found (86 +/- 4 micrograms/dl). The plasma zinc percent change over the period from 10 to 120 days of age was positively correlated with gestational age in the whole sample as well as in AGA and SGA infants separately.(ABSTRACT TRUNCATED AT 250 WORDS)
D001827:Body Height; D001835:Body Weight; D003300:Copper / Q000097:blood*; D005260:Female; D005865:Gestational Age; D006801:Humans; D007225:Infant Food; D007231:Infant, Newborn; D007234:Infant, Premature; D007236:Infant, Small for Gestational Age; D008297:Male; D015032:Zinc / Q000008:administration & dosage / Q000097:blood*
D003300:Copper; D015032:Zinc